News Summary The Jackson Laboratory (JAX) has acquired the New York Stem Cell Foundation (NYSCF), advancing automation in life sciences research. This acquisition enables JAX
News Summary The expiration of the Small Business Innovation Research (SBIR) program has created significant risks for New York’s biotechnology sector. The program, crucial for
News Summary AstraZeneca is planning to directly list its shares on the New York Stock Exchange, shifting away from Nasdaq’s American depositary receipts. This decision
News Summary Volastra Therapeutics, a drug-discovery company in Harlem, successfully raised over $30 million in a new venture capital round. The funding, backed by 11
News Summary The impending expiration of the Small Business Innovation Research (SBIR) program threatens New York’s biotech sector, vital for early-stage research funding. Home to
News Summary Pfizer Inc. has agreed to acquire Metsera, an obesity startup, for approximately $4.9 billion to enhance its weight-loss drug portfolio. The deal includes
News Summary New York City’s life sciences sector is on an upward trajectory despite facing significant funding hurdles. Employment in the field has grown at
News Summary Barclay Damon, LLP has launched a national pharmacy team comprising a multidisciplinary group of attorneys to offer legal services in the pharmacy and
News Summary MVP Health Care has agreed to a $250,000 settlement in New York due to a significant inaccuracy in its mental health provider directory.
News Summary The Health Resources and Services Administration has announced a pilot program to reform the 340B drug discount program, a vital source of savings
